13 09, 2023

Is Rocket Pharmaceuticals a Buy as the Stock Soars on FDA Trial Update? 3 Things to Consider

By |2023-12-07T19:52:55+00:00September 13th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Gene therapy developer Rocket Pharmaceuticals (RCKT) investors woke up in delight as shares skyrocketed in Wednesday morning’s pre-market trading session. When the bell sounded, the stock continued its trajectory and it currently sits 38% higher than it last closed at. This comes after the company announced that it has aligned with the Food and [...]

20 07, 2023

Johnson & Johnson Jumps 6% on Earnings Beat and Revised Guidance: Does it Deserve a Buy?

By |2023-12-07T20:46:04+00:00July 20th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

Johnson & Johnson (JNJ) has had its ups and downs over the past few months, but it appears as if steady growth is ahead. The company has boosted its previous guidance for the year after Thursday’s earnings report came in well above analyst expectations. Johnson & Johnson saw sales growth of 6.3% for the [...]

18 07, 2023

AudioCodes is Down 55% This Year, and it May Get Worse: Time to Sell?

By |2023-12-07T20:46:09+00:00July 18th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , , |

Recursion Pharmaceuticals (RXRX) just got an endorsement from one of Wall Street’s hottest stocks at the moment, and as such, has earned the attention of analysts, retail investors, and professionals alike. After securing a $50 million investment from Nvidia (NVDA), the RXRX shot up more than 76%. The two companies are more alike than [...]

30 06, 2023

Is it Time to Sell Walgreens Stock Amidst Dwindling Consumer Spending & COVID-Vax Demand?

By |2023-12-07T20:46:41+00:00June 30th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

Earlier this week, Walgreens (WBA) warned investors that profits would take a dive from previous estimates as a result of weakened consumer spending and dwindling demand for COVID-19 vaccinations. As a result, shares dropped more than 9% this week - now reaching their lowest levels in over a decade. CEO Rosalind Brewer noted that [...]

27 06, 2023

One Analyst Predicts Canopy Growth is Headed to Zero, Should You Cut Losses and Move On?

By |2023-12-07T20:46:54+00:00June 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

At one point, Canopy Growth (CGC) was valued at $19 billion. The stock traded at over $50/share at its peak. But today? It sits at a mere $0.49/share. And as dramatic a fall from grace as this story already is, one analyst expects the true end is near. Benchmark analyst Mike Hickey believes Canopy [...]

26 06, 2023

Eli Lilly is Up 38% in the Past 3 Months: What Keeps Pushing the Stock Higher, and Will it Continue?

By |2023-12-07T20:46:59+00:00June 26th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

While much of the recent focus within the stock market has been placed on the AI trend, one stock in the pharmaceutical industry has been on a surge so far this year: Eli Lilly (LLY). The stock sat at just $311/share at the start of March. And today, the stock sits at $452/share. But, [...]

15 05, 2023

Columbia Care is Up 20% After Earnings, But We Still See 3 Issues Investors Need to Be Aware Of

By |2023-12-07T20:50:59+00:00May 15th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Columbia Care Inc. (CCHWF) started the week with a bang, releasing its 1st quarter earnings report and exceeding analyst expectations. As a result, the stock has climbed more than 20%. But as you’ll discover below, there are still 3 major issues investors should be aware of. The cannabis company posted revenue of $124.54 million, [...]

1 05, 2023

Will Protalix BioTherapeutics Keep Powering Higher After its 178% Run Up Since November 2022?

By |2023-12-07T20:56:34+00:00May 1st, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Protalix BioTherapeutics, Inc. (PLX: NYSE AMEX and Tel Aviv Stock Exchange) is headquartered in Carmiel, Israel with an office in Hackensack, NJ, with a total of 197 employees. Protalix Ltd. was incorporated in 1993. It became a U.S public company on December 31, 2006. PLX is a biopharmaceutical company that develops, produces and commercializes [...]

18 04, 2023

Amneal Pharma Issues Guidance Over Market Forecasts, But We See 3 Things Holding the Stock Back

By |2023-12-07T20:57:13+00:00April 18th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , |

Yesterday, Amneal Pharmaceuticals (AMRX) issued guidance for the first quarter of 2023 that came in over the consensus estimates. This sent shares trading as much as 14% higher in premarket trading. The stock opened Monday’s trading session at $1.34/share and closed at $1.63 for a nice single-day gain. The pharmaceutical company says that revenue [...]

14 04, 2023

Why is UnitedHealth Falling After Beating Earnings Expectations and Raising Guidance?

By |2023-12-07T20:57:23+00:00April 14th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

This morning, UnitedHealth Group (UNH) reported first-quarter earnings that came in over expectations. The company doubled down on this success, raising the full-year outlook for 2023. And yet, shares of the company are falling - down nearly 3% in Friday’s trading session so far. This has investors and the market as a whole perplexed. [...]

Go to Top